Statistics
Publications
6
Citations
120
H-Index
6
Active since
2020
Affiliations
Shiru Zhang is an author at Nanjing Tech University specializing in pharmacology, epidemiology, and oncology.
Publications per year
2020–2024
6
6
Mechanism of hepatotoxicity of first-line tyrosine kinase inhibitors: Gefitinib and afatinib
Yao Zhang, Yang Cai, Shiru Zhang et al. · Toxicology Letters · 2021 · 25 citations
Pharmacy, Oncology, Pharmacology +12
1–5 of 6